ribosa

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• athletic performance [Possibly Ineffective]
• CABG [Insufficient Evidence]
• CAD [Possibly Effective]
• CHF [Insufficient Evidence]
• chronic fatigue syndrome [Insufficient Evidence]
• cognitive function [Insufficient Evidence]
• fibromyalgia [Insufficient Evidence]
• McArdle dz [Possibly Ineffective]
• exercise-induced muscle soreness [Insufficient Evidence]
• restless legs syndrome [Insufficient Evidence]
• seizures [Insufficient Evidence]

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies w/ variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

CAD

[Possibly Effective]

Dose: 15 g PO qid

CHF

[Insufficient Evidence]

Dose: 5 g PO tid

chronic fatigue syndrome

[Insufficient Evidence]

Dose: 5 g PO tid

fibromyalgia

[Insufficient Evidence]

Dose: 5 g PO tid

exercise-induced muscle soreness

[Insufficient Evidence]

Dose: 15 g PO x1 given 1h before exercise, 15 mg PO x1 given 1h after exercise, then 15 g PO q12h x3 doses